MARTINI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.901
AS - Asia 2.076
EU - Europa 1.276
SA - Sud America 320
AF - Africa 312
Continente sconosciuto - Info sul continente non disponibili 81
OC - Oceania 27
Totale 6.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.706
SG - Singapore 577
VN - Vietnam 466
IT - Italia 396
CN - Cina 295
HK - Hong Kong 247
BR - Brasile 201
ES - Italia 172
DE - Germania 76
FR - Francia 74
IN - India 68
BD - Bangladesh 67
FI - Finlandia 66
NL - Olanda 55
RU - Federazione Russa 55
GB - Regno Unito 53
PL - Polonia 51
CA - Canada 40
TR - Turchia 34
MX - Messico 32
SE - Svezia 30
AR - Argentina 29
JP - Giappone 28
PH - Filippine 27
IQ - Iraq 25
AT - Austria 24
ZA - Sudafrica 23
ID - Indonesia 20
UA - Ucraina 20
CZ - Repubblica Ceca 19
EC - Ecuador 18
IE - Irlanda 16
KR - Corea 16
BJ - Benin 13
CR - Costa Rica 13
CY - Cipro 13
JM - Giamaica 13
AL - Albania 12
JO - Giordania 12
MA - Marocco 12
PK - Pakistan 12
SA - Arabia Saudita 12
TZ - Tanzania 12
UZ - Uzbekistan 12
VE - Venezuela 12
BE - Belgio 11
BO - Bolivia 11
CH - Svizzera 11
CI - Costa d'Avorio 11
CL - Cile 11
CO - Colombia 11
EG - Egitto 11
KE - Kenya 11
MY - Malesia 11
NE - Niger 11
RE - Reunion 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
CU - Cuba 10
IL - Israele 10
RO - Romania 10
RW - Ruanda 10
YT - Mayotte 10
AO - Angola 9
ET - Etiopia 9
KZ - Kazakistan 9
LY - Libia 9
PY - Paraguay 9
SC - Seychelles 9
SN - Senegal 9
TW - Taiwan 9
AM - Armenia 8
BA - Bosnia-Erzegovina 8
BB - Barbados 8
DK - Danimarca 8
EE - Estonia 8
HU - Ungheria 8
LC - Santa Lucia 8
ME - Montenegro 8
MG - Madagascar 8
MK - Macedonia 8
NO - Norvegia 8
RS - Serbia 8
TH - Thailandia 8
AU - Australia 7
BY - Bielorussia 7
CG - Congo 7
CW - ???statistics.table.value.countryCode.CW??? 7
GF - Guiana Francese 7
HN - Honduras 7
IR - Iran 7
KH - Cambogia 7
LV - Lettonia 7
MN - Mongolia 7
NI - Nicaragua 7
NP - Nepal 7
PA - Panama 7
PR - Porto Rico 7
PT - Portogallo 7
XK - ???statistics.table.value.countryCode.XK??? 7
Totale 6.654
Salva come PNG Salva come JPEG
Città #
San Jose 430
Ashburn 402
Singapore 338
Hong Kong 222
Fairfield 190
Ho Chi Minh City 142
Hanoi 133
Woodbridge 130
Sabadell 116
Chandler 103
Los Angeles 102
Santa Clara 86
Houston 69
Cambridge 67
Seattle 62
Wilmington 51
Ann Arbor 49
Council Bluffs 45
Boardman 44
New York 44
Padova 37
Beijing 36
Matadepera 34
Milan 34
Munich 33
Lauterbourg 31
Chicago 29
Da Nang 29
Helsinki 29
Bytom 28
Rome 28
San Diego 28
Orem 25
Naples 24
São Paulo 24
Guangzhou 19
Turku 19
Brooklyn 18
Dong Ket 18
Buffalo 17
Medford 17
Phoenix 17
Princeton 17
Montreal 16
Padua 16
Tokyo 16
Johannesburg 15
London 15
Baghdad 14
Des Moines 14
Haiphong 14
Hefei 14
Cotonou 13
Shanghai 13
Dublin 12
Nuremberg 12
Abidjan 11
Amsterdam 11
Dallas 11
Redondo Beach 11
Amman 10
Frankfurt am Main 10
Havana 10
Kigali 10
Kyiv 10
Mexico City 10
Niamey 10
Rio de Janeiro 10
Tashkent 10
Ankara 9
Dakar 9
Hyderabad 9
Istanbul 9
Kingston 9
Nha Trang 9
Seoul 9
Stockholm 9
Villafranca Padovana 9
Vũng Tàu 9
Warsaw 9
Addis Ababa 8
Antananarivo 8
Atlanta 8
Bialystok 8
Boston 8
Castries 8
Dearborn 8
Jacksonville 8
Lappeenranta 8
Manchester 8
Podgorica 8
Roxbury 8
San José 8
Bridgetown 7
Dar es Salaam 7
Denver 7
Hangzhou 7
Harare 7
Lahore 7
Limassol 7
Totale 3.986
Salva come PNG Salva come JPEG
Nome #
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study 423
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 350
Tocilizumab for severe COVID-19 pneumonia 320
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 290
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma 288
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 276
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 271
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 239
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 237
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer 237
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 229
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 225
Occult liver disease burden: Analysis from a large general practitioners’ database 222
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 217
Natural history of acute kidney disease in patients with cirrhosis 203
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 201
SQUAMOUS CELL CARCINOMA ANTIGEN- IMMUNOGLOBULIN M (SCCA-IGM) AS BIOMARKER IN LIVER DISEASE: BIOLOGICAL ASPECTS AND CLINICAL APPLICATIONS 196
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 189
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C 179
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 173
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases 164
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies 164
Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients 161
SerpinB3: A Multifaceted Player in Health and Disease—Review and Future Perspectives 148
Liver pro-oncogenic potential of SERPINB3. 140
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma 134
SERPINB3 INCREASES RESISTANCE TO CISPLATIN-INDUCED CELL DEATH IN HEPATOMA CELLS THROUGH INHIBITION OF THE PERMEABILITY TRANSITON PORE 128
Human epididymis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathies 122
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 120
Predictors of Persistent Disease Activity and Damage in Systemic Sclerosis: Associations With Mortality in a Single-Center Cohort Study 103
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma 98
Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus Bevacizumab 96
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study 94
The Role of PAR2 in MASLD Progression and HCC Development 81
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma 78
Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma 78
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 75
Outcome of hepatic resection for HCC in ideal and non-ideal candidates 44
Totale 6.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.344
article - articoli 17.764
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 580
Totale 36.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022249 0 49 12 12 17 24 23 12 10 17 19 54
2022/2023196 38 22 8 20 29 22 1 16 27 2 8 3
2023/2024200 3 22 23 20 17 19 20 12 9 14 15 26
2024/2025939 12 70 52 53 69 26 64 61 74 51 151 256
2025/20264.479 238 249 462 591 526 219 858 331 451 248 198 108
2026/2027257 193 64 0 0 0 0 0 0 0 0 0 0
Totale 6.993